Clinical Evaluation of Adjusted Doses of Darunavir/Ritonavir With Rifampicin in HIV-infected Volunteers
Condition:   HIV Infections Interventions:   Drug: Darunavir/ritonavir 800/100 mg tablet;   Drug: Rifampicin 600mg QD tablet and DTG 50mg BD Sponsors:   University of Cape Town;   Wits Reproductive Health and HIV Institute;   Desmond Tutu HIV Centre Terminated (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 27, 2019 Category: Research Source Type: clinical trials

Impact of Steady State Cobicistat and Darunavir/Cobicistat on the Pharmacokinetics and Pharmacodynamic of Oral Anticoagulants (Rivaroxaban, Apixaban) in Health Volunteers
Condition:   Healthy Volunteers Interventions:   Drug: Tybost (Cobicistat);   Drug: Prezcobix (Darunavir/Cobicistat);   Drug: Xarelto (Rivaroxaban);   Drug: Eliquis (Apixaban) Sponsor:   National Institutes of Health Clinical Center (CC) Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 6, 2019 Category: Research Source Type: clinical trials